Beijing Highthink Pharmaceutical Technology Service Co., Ltd. (Highthink Med) is a leading China-based Contract Research Organization (CRO) providing comprehensive Phase I-IV clinical research and technical services. The company supports pharmaceutical, medical device, and new drug development institutions with services including clinical operations, medical affairs, data management, biostatistics, pharmacovigilance, and regulatory affairs.
Founded in 2006, Highthink Med has established a strong presence in the Chinese market, collaborating with over 400 medical institutions and tertiary hospitals. The company is recognized for its internationalized management and quality control systems, including proprietary eCTD submission capabilities that meet FDA, EMA, and NMPA requirements. It is currently in the process of IPO registration.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Venture Capital-Backed
Total Raised:$44M
Investors:CITIC Securities Investment Company, Central SOEs Industrial Investment Fund for Poor Area, Renhe Capital, CICC Capital, Roton Capital
PIPELINE
Stage:Service Provider
Modalities:Small molecule, Biologics, Cell therapy, Gene therapy
Active Trials:2
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Apeloa Pharmaceutical (Clinical trial support), Excyte LLC (Phase Ib/II study)
COMPETITION
Position:Challenger
Competitors:WuXi AppTec, Pharmaron, Tigermed
LEADERSHIP
Key Executives:
Qi Xuebing - Chairman/Actual Controller
Leon Sun - Chief Science Officer
Zheng Kai - Board Secretary
LINKS
Website:highthinkmed.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Beijing Highthink Pharmaceutical Technology Service Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Beijing Highthink Pharmaceutical Technology Service Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.